atai Life Sciences to Participate in Upcoming June Healthcare Conferences
16 June 2022 - 07:59PM
atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage
biopharmaceutical company aiming to transform the treatment of
mental health disorders, will participate in the following upcoming
healthcare conferences in June:
- BIO International Conference
Format:
Company Presentation – In
Person Date
and Time: Thursday, June 16th, 2:45 p.m. ET – 3:15 p.m.
ET Conference
Link: URL
- H.C. Wainwright 1st
Annual Mental Health Conference
Format:
Company Presentation –
Hybrid Date
and Time: Monday, June 27th, 12:00 p.m. ET – 12:30 p.m.
ET Conference
Link: URL
The presentation and archived webcast will also be accessible in
the Events section of atai’s website.
About atai Life Sciences atai is a
clinical-stage biopharmaceutical company aiming to transform the
treatment of mental health disorders. atai was founded in 2018 as a
response to the significant unmet need and lack of innovation in
the mental health treatment landscape. atai is dedicated to
acquiring, incubating and efficiently developing innovative
therapeutics to treat depression, anxiety, addiction, and other
mental health disorders.
atai's business model combines funding, technology, scientific
and regulatory expertise with a focus on psychedelic therapy and
non-psychedelic compounds with differentiated safety profiles and
therapeutic potential. By pooling resources and best practices,
atai aims to responsibly accelerate the development of new
medicines across its companies, seeking to effectively treat and
ultimately heal mental health disorders.
atai's vision is to heal mental health disorders so that
everyone, everywhere can live a more fulfilled life. For more
information, please visit www.atai.life.
Forward-Looking StatementsThese presentations
may contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Any express or
implied statements contained in these presentations that are not
statements of historical fact may be deemed to be forward-looking
statements. Forward-looking statements are neither promises nor
guarantees, but involve known and unknown risks and uncertainties
that could cause actual results to differ materially from those
projected, including, without limitation, the important factors
described in the section titled “Risk Factors” in our most recent
Annual Report on Form 10-K filed with the Securities and Exchange
Commission (“SEC”), as updated by our subsequent filings with the
SEC, as such factors may be updated from time to time in atai's
other filings with the SEC. atai disclaims any obligation or
undertaking to update or revise any forward-looking statements
contained in this press release, other than to the extent required
by applicable law.
Contact Information
Investor Contact:Greg Weaver,Chief Financial Officer, atai Life
SciencesEmail: IR@atai.life
Media Contact:Allan Malievsky,Senior Director, External Affairs
Email: allan@atai.life
ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From Feb 2024 to Mar 2024
ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From Mar 2023 to Mar 2024